Home » About Us » Our Leadership

Our Leadership

Catalent has attracted a world-class array of strategic and operational talent to lead us into cutting-edge innovation and reliable supply for our customers. Meet our Biologics and Gene Therapy Senior Leadership Teams below.

Biologics Leadership

KAREN FLYNN

President, Biologics &
Chief Commercial Officer

PETE BUZY

President, Paragon Gene Therapy

MIKE RILEY

Region President,
Biologics,
North America

MANJA BOERMAN, PH.D.

Region President,
Biologics, Europe

VIC VINCI, PH.D.

Vice President, Product Development

KATHLEEN MUNSTER

Vice President, Quality

GREG BLECK, PH.D.

Global Head of R&D, Biologics

DENIS JOHNSON

General Manager,
Bloomington

GRAHAM BREARLEY, PH.D.

General Manager,
Madison

KARIM ABDELKADER

Vice President, Business Development, Drug Product

ANTHONY SHEEHAN

Vice President, Business Development, Drug Product,
Europe

BERNIE CLARK

Vice President,
Marketing & Strategy

MARIA VIRGINIA POLI

Associate
General Counsel

REKHA PATEL

Director, Biologics Analytical Solutions

FRANK LI, PH.D.

Director,
Process Development

Gene Therapy Leadership

Biologics Advisory Board

Redwood Scientific Advisory Board